Impact of combined lipid lowering with blood pressure control on coronary plaque regression: rationale and design of MILLION study
Masa‐aki Kawashiri(Kanazawa University), Masakazu Yamagishi(Kanazawa University), Kenji Miwa(Ishikawa Prefectural Central Hospital), Tadatsugu Gamou, Keisuke Nagase(Kanazawa University), Masanobu Namura(Kanazawa Hospital), Hidekazu Ino(Kanazawa University), Kenshi Hayashi(Kanazawa University), Shoji Katsuda(Red Cross Hospital), Kazuyasu Okeie(Kouseiren Takaoka Hospital), Kenji Sakata(Kanazawa University), Yutaka Nitta, Mitsuyasu Terashima(Toyohashi Heart Center), Hiroaki Hirase(Kouseiren Takaoka Hospital), Tetsuo Konno(Kanazawa University), Hayato Tada(Kanazawa University), Sumio Mizuno(Fukui CardioVascular Center), Toshinori Higashikata(Kanazawa University), Honin Kanaya(Ishikawa Prefectural Central Hospital), Kosei Ueda(Ueda Womens Junior College), Ichiro Michishita(Yokohama Sakae Kyosai Hospital), Katsuharu Uchiyama(Kouseiren Takaoka Hospital)
Cited by 10
Related Papers
Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-β
|Journal of Clinical Investigation|2010|440
Effect of Intensive Statin Therapy on Regression of Coronary Atherosclerosis in Patients With Acute Coronary Syndrome
|Journal of the American College of Cardiology|2009|359
Antiplatelet Therapy and Stent Thrombosis After Sirolimus-Eluting Stent Implantation
|Circulation|2009|358